GlassScriptPhysician profile
Dylan B Belt
NPI 1982612800
$6,272.29
in general payments reported to CMS, 2019-2025
14 companies · $630 in 2025
The $630 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,509 · 2020: $176 · 2021: $643 · 2022: $191 · 2023: $752 · 2024: $1,372 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,611 · Entertainment: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,611.16 |
| Entertainment | $142.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,728.09 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $883.87 | 2022-2025 | Infuse, Biotrue, Vyzulta |
| Biotissue Holdings INC. | $847.00 | 2023-2024 | |
| Alcon Vision LLC | $674.01 | 2021-2025 | Total30, Dailies Total1 |
| Topcon Healthcare, INC. | $311.94 | 2021-2025 | |
| Tarsus Pharmaceuticals, INC. | $145.18 | 2024 | Xdemvy |
| Optos, INC. | $142.35 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $119.60 | 2021 | |
| Sun Pharmaceutical Industries INC. | $104.33 | 2022-2023 | Cequa |
| Genzyme Corporation | $104.22 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $101.04 | 2019 | |
| Allergan, INC. | $67.66 | 2019 | |
| Oyster Point Pharma, INC. | $23.00 | 2023 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $20.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Belt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.